Lipocine
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Lipocine and other ETFs, options, and stocks.About LPCN
Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of the delivery of drugs using proprietary delivery technology. It offers TLANDO, an oral testosterone replacement therapy.
CEOMahesh V. Patel
CEOMahesh V. Patel
Employees16
Employees16
HeadquartersSalt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded2011
Founded2011
Employees16
Employees16
LPCN Key Statistics
Market cap58.27M
Market cap58.27M
Price-Earnings ratio-10.28
Price-Earnings ratio-10.28
Dividend yield—
Dividend yield—
Average volume233.07K
Average volume233.07K
High today$11.00
High today$11.00
Low today$9.82
Low today$9.82
Open price$10.36
Open price$10.36
Volume46.46K
Volume46.46K
52 Week high$12.37
52 Week high$12.37
52 Week low$2.52
52 Week low$2.52
Stock Snapshot
Lipocine(LPCN) stock is priced at $10.50, giving the company a market capitalization of 58.27M. It carries a P/E multiple of -10.28.
On 2026-01-23, Lipocine(LPCN) stock traded between a low of $9.82 and a high of $11.00. Shares are currently priced at $10.50, which is +6.9% above the low and -4.6% below the high.
Lipocine(LPCN) shares are trading with a volume of 46.46K, against a daily average of 233.07K.
During the past year, Lipocine(LPCN) stock moved between $2.52 at its lowest and $12.37 at its peak.
During the past year, Lipocine(LPCN) stock moved between $2.52 at its lowest and $12.37 at its peak.
People also own
Based on the portfolios of people who own LPCN. This list is generated using Robinhood data, and it’s not a recommendation.